Zusammenfassung
Dieses große Kapitel fasst die nichtneoplastischen und neoplastischen Erkrankungen der Schilddrüse zusammen, wobei auf der Basis der WHO-Klassifikation detailliert in Bild und Text auf die morphologischen Erscheinungsformen eingegangen wird. Gleichzeitig werden die wichtigsten Informationen zu Epidemiologie, Genetik und Biologie zusammengestellt.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Adeniran AJ, Zhu Z, Gandhi M, Steward DL, Fidler JP, Giordano TJ, Biddinger PW, Nikiforov YE (2006) Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 30:216–222
Adnan Z, Arad E, Dana J, Shendler Y, Baron E (2013) Simultaneous occurrence of medullary and papillary thyroid microcarcinomas: a case series and review of the literature. J Med Case Rep 7:26
Agaimy A, Hahn T, Schroeder J, Elhag A (2012) Follicular thyroid adenoma dominated by spindle cells: report of two unusual cases and literature review. Int J Clin Exp Pathol 5:143–151
Agaimy A, Erlenbach-Wünsch K, Konukiewitz B, Schmitt AM, Rieker RJ, Vieth M, Kiesewetter F, Hartmann A, Zamboni G, Perren A, Klöppel G (2013) ISL1 expression is not restricted to pancreatic well differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrahepatic origin. Mod Pathol 26:995–1003
Ahmed R, Al-Shaikh S, Akhtar M (2012) Hashimoto thyroiditis: a century later. Adv Anat Pathol 19:181–186
Albores-Saavedra J, Monforte H, Nadji M, Morales AR (1988) C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. Hum Pathol 19:795–799
Albores-Saavedra J, Gould E, Vardaman C, Vuitch F (1991) The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases. Hum Pathol 22:1195–1205
Albores-Saavedra J, Carrick K (2004) Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid. Endocr Pathol 15:297–305
Alexander CB, Herrera GA, Jaffe K, Yu H (1985) Black thyroid: clinical manifestations, ultrastructural findings, and possible mechanisms. Hum Pathol 16:72–78
Alzouebi M, Goepel JR, Horsman JM, Hancock BW (2012) Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre. Int J Oncol 40:2075–2080
Amal B, El Fatemi H, Souaf I, Moumna K, Affaf A (2013) A rare primary tumor of the thyroid gland: report a new case of leiomyosarcoma and literature review. Diagn Pathol 8:36
Apel RL, Ezzat S, Bapat BV, Pan N, LiVolsi VA, Asa SL (1995) Clonality of thyroid nodules in sporadic goiter. Diagn Mol Pathol 4:113–121
Arora N, Scognamiglio T, Zhu B, Fahey TJ 3rd (2008) Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg 32:1237–1246
Asa SL (2004) My approach to oncocytic tumours of the thyroid. J Clin Pathol 57:225–232
Bahn RS (2010) Graves’ ophthalmopathy. N Engl J Med 362:726–738
Baloch ZW, LiVolsi VA (1999) Post fine-needle aspiration histologic alterations of thyroid revisited. Am J Clin Pathol 112:311–316
Baloch ZW, LiVolsi VA (2000) Warthin-like papillary carcinoma of the thyroid. Arch Pathol Lab Med 124:1192–1195
Baloch ZW, LiVolsi VA (2000) Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol 13:861–865
Baloch ZW, Solomon AC, LiVolsi VA (2000) Primary mucoepidermoid carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: report of nine cases. Mod Pathol 13:802–807
Baloch ZW, Puttaswamy K, Brose M, LiVolsi VA (2006) Lack of BRAF mutations in hyalinizing trabecular neoplasm. Cytojournal 3:17
Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ (2008) Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:425–437
Barclay ML, Brownlie BE, Turner JG, Wells JE (1994) Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol (Oxf) 40:759–764
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
Baschieri L, Castagna M, Fierabracci A, Antonelli A, Del Guerra P, Squartini F (1989) Distribution of calcitonin- and somatostatin-containing cells in thyroid lymphoma and in Hashimoto’s thyroiditis. Appl Pathol 7:99–104
Basolo F, Giannini R, Monaco C, Melillo RM, Carlomagno F, Pancrazi M, Salvatore G, Chiappetta G, Pacini F, Elisei R, Miccoli P, Pinchera A, Fusco A, Santoro M (2002) Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. Am J Pathol 160:247–254
Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B, Cailleux AF, Lumbroso JD, Parmentier C, Schlumberger M (1998) Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 83:553–559
Beerman H, Rigaud C, Bogomoletz WV, Hollander H, Veldhuizen RW (1990) Melanin production in black medullary thyroid carcinoma (MTC). Histopathology 16:227–233
Berger SA, Zonszein J, Villamena P, Mittman N (1983) Infectious diseases of the thyroid gland. Rev Infect Dis 5:108–122
Bergholm U, Bergström R, Ekbom A (1997) Long-term follow-up of patients with medullary carcinoma of the thyroid. Cancer 79:132–138
Bernstein JI, Virk R, Hui P, Prasad A, Westra WH, Tallini G, Adeniran AJ, Udelsman R, Sasaki CT, Roman S, Sosa JA, Prasad ML (2013) Tall cell variant of papillary thyroid microcarcinoma: clinicopathological features with BRAFV600E mutational analysis. Thyroid 23:1525–1531
Blasius S, Edel G, Grünert J, Böcker W, Schmid KW (1994) Anaplastic thyroid carcinoma with osteosarcomatous differentiation. Pathol Res Pract 190:507–510
Bockhorn M, Frilling A, Rewerk S, Liedke M, Dirsch O, Schmid KW, Broelsch CE (2004) Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid 14:468–470
Bockhorn M, Sheu SY, Frilling A, Molmenti E, Schmid KW, Broelsch CE (2005) Paraganglioma-like medullary thyroid carcinoma: a rare entity. Thyroid 15:1363–1367
Bondeson L, Ljungberg O (1981) Occult thyroid carcinoma at autopsy in Malmö, Sweden. Cancer 47:319–323
Boos LA, Dettmer M, Schmitt A, Rudolph T, Steinert H, Moch H, Sobrinho-Simões M, Komminoth P, Perren A (2013) Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas – a TMA-based study of 226 cases. Histopathology 63:234–241
Booya F, Sebo TJ, Kasperbauer JL, Fatourechi V (2006) Primary squamous cell carcinoma of the thyroid: report of ten cases. Thyroid 16:89–93
Brauckhoff M, Machens A, Hess S, Lorenz K, Gimm O, Brauckhoff K, Sekulla C, Dralle H (2008) Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis. Surgery 144:1044–1050
Brauer VF, Scholz GH, Neumann S, Lohmann T, Paschke R, Koch CA (2004) RET germline mutation in codon 791 in a family representing 3 generations from age 5 to age 70 years: should thyroidectomy be performed? Endocr Pract 10:5–9
Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD (2008) The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 93:504–515
Brzeziańska E, Pastuszak-Lewandoska D, Lewiński A (2007) Rearrangements of NTRK1 oncogene in papillary thyroid carcinoma. Neuro Endocrinol Lett 28:221–229
Bülow C, Bülow S (1997) Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group. Int J Colorectal Dis 12:240–242
Burke BA, Johnson D, Gilbert EF, Drut RM, Ludwig J, Wick MR (1987) Thyrocalcitonin-containing cells in the Di George anomaly. Hum Pathol 18:355–360
Burt AD, MacGuire J, Lindop GB, Browne MK (1987) Mixed follicular-parafollicular carcinoma of the thyroid. Scott Med J 32:50–51
Cakir M, Altunbas H, Balci MK, Karayalcin U, Karpuzoglu G (2002) Medullary thyroid carcinoma, follicular variant. Endocr Pathol 13:75–79
Cameselle-Teijeiro J, Chan JK (1999) Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol 12:400–411
Cameselle-Teijeiro J (2011) Uncommon tumors of the thyroid gland. Int J Surg Pathol 18:205–208
Cameselle-Teijeiro J, Ferreira R, Caramés N, Abdulkader I, Máximo V, Soares P, Sobrinho-Simões M (2012) Absence of the BRAF and the GRIM-19 mutations in oncocytic (Hürthle cell) solid cell nests of the thyroid. Am J Clin Pathol 137:612–618
Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676–690
Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde Struma”. Am J Surg Pathol 8:655–668
Carcangiu ML, Steeper T, Zampi G, Rosai J (1985) Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol 83:135–158
Carcangiu ML, Bianchi S (1989) Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol 13:1041–1049
Carney JA, Ryan J, Goellner JR (1987) Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 11:583–591
Carney JA, Hirokawa M, Lloyd RV, Papotti M, Sebo TJ (2008) Hyalinizing trabecular tumors of the thyroid gland are almost all benign. Am J Surg Pathol 32:1877–1889
Castro P, Rebocho AP, Soares RJ, Magalhães J, Roque L, Trovisco V, de Vieira Castro I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simões M (2006) PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 91:213–220
Cavaco BM, Batista PF, Martins C, Banito A, do Rosário F, Limbert E, Sobrinho LG, Leite V (2008) Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Endocr Relat Cancer 15:207–215
Chan JK, Tse CC (1989) Solid cell nest-associated C-cells: another possible explanation for ″C-cell hyperplasia″ adjacent to follicular cell tumors. Hum Pathol 20:498–499
Chan JK, Rosai J (1991) Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Hum Pathol 22:349–367
Chan JKC (2007) Tumors of the thyroid and parathyroid glands. In: Fletcher CDM (Hrsg) Diagnostic Histopathology of Tumors, 3. Aufl. Bd. 2. Churchill Livingstone, London, S 997–1079 (Chapter 18)
Charkes ND (2006) On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid 16:181–186 (Erratum in: Thyroid 16: 520)
Chazenbalk GD, Pichurin P, Chen CR, Latrofa F, Johnstone AP, McLachlan SM, Rapoport B (2002) Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. J Clin Invest 110:209–217
Chen H, Nicol TL, Zeiger MA, Dooley WC, Ladenson PW, Cooper DS, Ringel M, Parkerson S, Allo M, Udelsman R (1998) Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Ann Surg 227:542–546
Chertok Shacham E, Ishay A, Irit E, Pohlenz J, Tenenbaum-Rakover Y (2012) Minimally invasive follicular thyroid carcinoma developed in dyshormonogenetic multinodular goiter due to thyroid peroxidase gene mutation. Thyroid 22:542–546
Chetty R (1990) Hürthle cell medullary carcinomas of the thyroid gland. S Afr J Surg 28:95–97
Chetty R (2011) Follicular patterned lesions of the thyroid gland: a practical algorithmic approach. J Clin Pathol 64:737–741
Cheuk W, Jacobson AA, Chan JK (2000) Spindle epithelial tumor with thymus-like differentiation (SETTLE): a distinctive malignant thyroid neoplasm with significant metastatic potential. Mod Pathol 13:1150–1155
Cheung CC, Boerner SL, MacMillan CM, Ramyar L, Asa SL (2000) Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics. Am J Surg Pathol 24:1622–1626
Cheung L, Messina M, Gill A, Clarkson A, Learoyd D, Delbridge L, Wentworth J, Philips J, Clifton-Bligh R, Robinson BG (2003) Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 88:354–357
Chiosea S, Nikiforova M, Zuo H, Ogilvie J, Gandhi M, Seethala RR, Ohori NP, Nikiforov YE (2009) A novel complex BRAF mutation detected in a solid variant ofpapillary thyroid carcinoma. Endocr Pathol 20:122–126
Chong GC, Beahrs OH, Sizemore GW, Woolner LH (1975) Medullary carcinoma of the thyroid gland. Cancer 35:695–704
Chow EJ, Friedman DL, Stovall M, Yasui Y, Whitton JA, Robison LL, Sklar CA (2009) Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 53:432–437
Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH (2003) Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer 98:31–40
Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN, Rabes HM, Fagin JA, Nikiforov YE (2005) Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 115:94–101
Ciampi R, Giordano TJ, Wikenheiser-Brokamp K, Koenig RJ, Nikiforov YE (2007) HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma. Endocr Relat Cancer 14(2):445–452
Clerici T, Kolb W, Beutner U, Bareck E, Dotzenrath C, Kull C, Niederle B, Kaserer K, Perren A, Schmid KW, Köberle-Wührer R, Wenzl E, Asari R, Klinge U, Müller G, Kroell KP, Blankenburg C, Voss H, Cupisti K, Witte J, Knoefel WT, Simon D, Lienenlüke RH, Vorländer C, Wacha H, Schabram J, Lorenz K, Dralle H, Wojciechowski B, Kussmann J, Weber Y, Schürmann G, Goretzki PE, Ulitzer H, Eberle A, Mayer M, Stabenow R, Stegmaier C, Bühlmann R, Schlumpf R, Triponez F, Ess SM (2010) Diagnosis and treatment of small follicular thyroid carcinomas. Br J Surg 97:839–844
Coli A, Bigotti G, Zucchetti F, Negro F, Massi G (2000) Papillary carcinoma in amyloid goitre. J Exp Clin Cancer Res 19:391–394
Collini P, Sampietro G, Rosai J, Pilotti S (2003) Minimally invasive (encapsulated) follicular carcinoma of the thyroid gland is the low-risk counterpart of widely invasive follicular carcinoma but not of insular carcinoma. Virchows Arch 442:71–76
Collini P, Sampietro G, Pilotti S (2004) Extensive vascular invasion is a marker of risk of relapse in encapsulated non-Hürthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with a 11-year median follow-up. Histopathology 44:35–39
Collins J, Gough S (2002) Autoimmunity in thyroid disease. Eur J Nucl Med Mol Imaging 29(2):417–S424
Coltrera MD (1999) Primary T-cell lymphoma of the thyroid. Head Neck 21:160–163
Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214
Corvi R, Martinez-Alfaro M, Harach HR, Zini M, Papotti M, Romeo G (2001) Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization. Lab Invest 81:1639–1645
Costinean S, Balatti V, Bottoni A, Old M, Croce C, Wakely PE Jr (2012) Primary intrathyroidal paraganglioma: histopathology and novel molecular alterations. Hum Pathol 43:2371–2375
Couto JP, Prazeres H, Castro P, Lima J, Máximo V, Soares P, Sobrinho-Simões M (2009) How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer. J Clin Pathol 62:414–421
Dahlgren M, Khosroshahi A, Nielson GP, Deshpande V, Stone JH (2010) Riedel’s Thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arth Care Res 62:1312–1318
D’Antonio A, Addesso M, De Dominicis G, Boscaino A, Liguori G, Nappi O (2007) Mucinous carcinoma of thyroid gland. Report of a primary and a metastatic mucinous tumour from ovarian adenocarcinoma with immunohistochemical study and review of literature. Virchows Arch 451:847–851
D’Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, Siperstein AE, Duh QY, Clark OH (2004) Follicular thyroid carcinoma: histology and prognosis. Cancer 100:1123–1129
Davies L, Welch HG (2006) Increasing incidence of thyroid cancer inthe United States, 1973–2002. JAMA 295:2164–2167
De Jong SA, Demeter JG, Jarosz H, Lawrence AM, Paloyan E (1993) Primary papillary thyroid carcinoma presenting as cervical lymphadenopathy: the operative approach to the ″lateral aberrant thyroid″. Am Surg 59:172–176
Delbridge L, Parkyn R, Philips J, Barraclough B, Robinson B (2002) Minimally invasive follicular thyroid carcinoma: completion thyroidectomy or not? ANZ J Surg 72:844–845
DeLellis RA, May L, Tashjian AH Jr, Wolfe HJ (1978) C-cell granule heterogeneity in man. An ultrastructural immunocytochemical study. Lab Invest 38:263–269
DeLellis RA, Wolfe HJ (1981) The pathobiology of the human calcitonin (C)-cell: a review. Pathol Annu 16:25–52
DeLellis RA, Lloyd RV, Heitz PU, Eng C (2004) WHO histological classification of thyroid and parathyroid tumours. In: World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of Endocrine Organs. IARC Press, Lyon
DeLellis RA, Shin SJ (2006) Immunohistology of Endocrine Tumors. In: Dabbs DJ (Hrsg) Diagnostic Immunohistochemistry. Churchill Livingstone, New York, S 261–300
de Lima MA, Dias Medeiros J, Rodrigues Da Cunha L, de Cássia Caldas Pessôa R, Silveira Tavares F, de Fátima Borges M, Marinho EO (2001) Cytological aspects of melanotic variant of medullary thyroid carcinoma. Diagn Cytopathol 24:206–208
de Matos PS, Ferreira AP, Ward LS (2006) Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series. Endocr Pathol 17:165–173
Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL (2000) Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 24:623–639
Desailloud R, Hober D (2009) Viruses and thyroiditis: an update. Virol J 6:5
Deshpande A, Bobhate SK (1995) Squamous cell carcinoma in thyroglossal duct cyst. J Laryngol Otol 109:1001–1004
Dettmer M, Schmitt A, Steinert H, Haldemann A, Meili A, Moch H, Komminoth P, Perren A (2011) Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed? Am J Surg Pathol 35:1866–1872
Dettmer M, Schmitt A, Steinert H, Moch H, Komminoth P, Perren A (2012) Poorly differentiated oncocytic thyroid carcinoma–diagnostic implications and outcome. Histopathology 60:1045–1051
de Vries MM, Celestino R, Castro P, Eloy C, Máximo V, van der Wal JE, Plukker JT, Links TP, Hofstra RM, Sobrinho-Simões M, Soares P (2012) RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas. Histopathology 61:833–843
Dionigi G, Castano P, Bertolini V, Boni L, Rovera F, Tanda ML, Capella C, Bartalena L, Dionigi R (2007) Simultaneous medullary and papillary thyroid cancer: two case reports. J Med Case Rep 1:133
Dockhorn-Dworniczak B, Franke WW, Schröder S, Czernobilsky B, Gould VE, Böcker W (1987) Patterns of expression of cytoskeletal proteins in human thyroid gland and thyroid carcinomas. Differentiation 35:53–71
Dominguez-Malagon H, Delgado-Chavez R, Torres-Najera M, Gould E, Albores-Saavedra J (1989) Oxyphil and squamous variants of medullary thyroid carcinoma. Cancer 63:1183–1188
Dralle H, Gimm O, Simon D, Frank-Raue K, Görtz G, Niederle B, Wahl RA, Koch B, Walgenbach S, Hampel R, Ritter MM, Spelsberg F, Heiss A, Hinze R, Höppner W (1998) Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 22:744–750
Dralle H, Machens A, Lorenz K (2008) Hereditäre Schilddrüsenkarzinome. Chirurg 79:1017–1028
Dralle H, Machens A (2012) Primary surgery for differentiated thyroid cancer in the new millennium. J Endocrinol Invest 35:10–15
Dralle H, Musholt TJ, Schabram J, Steinmüller T, Frilling A, Simon D, Goretzki PE, Niederle B, Scheuba C, Clerici T, Hermann M, Kußmann J, Lorenz K, Nies C, Schabram P, Trupka A, Zielke A, Karges W, Luster M, Schmid KW, Vordermark D, Schmoll HJ, Mühlenberg R, Schober O, Rimmele H, Machens A (2013) German Societies of General and Visceral Surgery; Endocrinology; Nuclear Medicine; Pathology; Radiooncology; Oncological Hematology; and the German Thyroid Cancer Patient Support Organization Ohne Schilddrüse leben e.V. German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg 398:347–375
Dube VEJGT (1971) Extreme squamous metaplasia in Hashimoto’s thyroiditis. Cancer 27:434–437
Eales JG (1988) The influence of nutritional stage on thyroid function in various vertebrates. Am Zool 20:351–362
Elisei R, Cosci B, Romei C, Bottici V, Renzini G, Molinaro E, Agate L, Vivaldi A, Faviana P, Basolo F, Miccoli P, Berti P, Pacini F, Pinchera A (2008) Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 93:682–687
Eloy JA, Mortensen M, Gupta S, Lewis MS, Brett EM, Genden EM (2007) Metastasis of uterine leiomyosarcoma to the thyroid gland: case report and review of the literature. Thyroid 17:1295–1297
Erovic BM, Kim D, Cassol C, Goldstein DP, Irish JC, Asa SL, Mete O (2012) Prognostic and predictive markers in medullary thyroid carcinoma. Endocr Pathol 23:232–242
Evans HL (1984) Follicular neoplasms of the thyroid. A study of 44 cases followed for a minimum of 10 years, with emphasis on differential diagnosis. Cancer 54:535–540
Evans HL (1987) Encapsulated papillary neoplasms of the thyroid. A study of 14 cases followed for a minimum of 10 years. Am J Surg Pathol 11:592–597
Fagin JA (2002) Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid. Mol Endocrinol 16:903–911
Falvo L, Giacomelli L, Vanni B, Marzollo A, Guerriero G, De Antoni E (2006) Papillary thyroid carcinoma in thyroglossal duct cyst: case reports and literature review. Int Surg 91:141–146
Ferri E, Manconi R, Armato E, Ianniello F (2009) Primary paraganglioma of thyroid gland: a clinicopathologic and immunohistochemical study with review of the literature. Acta Otorhinolaryngol Ital 29:97–102
Fink A, Tomlinson G, Freeman JL, Rosen IB, Asa SL (1996) Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Mod Pathol 9:816–820
Fonseca E, Nesland JM, Sobrinho-Simoes M (1997) Expression of stratified epithelial-type cytokeratins in hyalinizing trabecular adenomas supports their relationship with papillary carcinomas of the thyroid. Histopathology 31:330–335
Franc B, de la Salmonière P, Lange F, Hoang C, Louvel A, de Roquancourt A, Vildé F, Hejblum G, Chevret S, Chastang C (2003) Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum Pathol 34:1092–1100
Frank TS, LiVolsi VA, Connor AM (1987) Cytomegalovirus infection of the thyroid in immunocompromised adults. Yale J Biol Med 60:1–8
Frank-Raue K, Machens A, Scheuba C, Niederle B, Dralle H, Raue F (2008) German MEN2 Study Group. Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791. Clin Endocrinol (Oxf) 69:259–263
Frank-Raue K, Machens A, Leidig-Bruckner G, Rondot S, Haag C, Schulze E, Lorenz A, Kreissl MC, Dralle H, Raue F, Schmid KW (2013) Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma. Thyroid 23:294–300
Franssila KO, Harach HR, Wasenius VM (1984) Mucoepidermoid carcinoma of the thyroid. Cancer 53:1741–1745
Franssila KO, Harach HR (1986) Occult papillary carcinoma of the thyroid in children and young adults. A systemic autopsy study in Finland. Cancer 58:715–719
Fridman MV, Savva NN, Krasko OV, Zborovskaya AA, Mankovskaya SV, Schmid KW, Demidchik YE (2012) Clinical and pathologic features of ″sporadic″ papillary thyroid carcinoma registered in the years 2005 to 2008 in children and adolescents of Belarus. Thyroid 22:1016–1024
Führer D, Holzapfel HP, Wonerow P, Scherbaum WA, Paschke R (1997) Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab 82:3885–3891
Führer D (2001) A nuclear receptor in thyroid malignancy: is PAX8/PPARgamma the Holy Grail of follicular thyroid cancer? Eur J Endocrinol 144:453–456
Führer D, Schmid KW (2010) Benigner Schilddrüsenknoten oder Schilddrüsenmalignom? Internist (Berl) 51:611–619
Fukunaga FH, Lockett LJ (1971) Thyroid carcinoma in the Japanese in Hawaii. Arch Pathol 92:6–13
Fukunaga FH, Yatani R (1975) Geographic pathology of occult thyroid carcinomas. Cancer 36:1095–1099
Fukushima M, Ito Y, Hirokawa M, Akasu H, Shimizu K, Miyauchi A (2009) Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: an 18-year experience at a single institution. World J Surg 33:958–962
Furlan JC, Bedard YC, Rosen IB (2007) Significance of tumor capsular invasion in well-differentiated thyroid carcinomas. Am Surg 73:484–491
Gemsenjäger E, Heitz PU, Martina B (1997) Selective treatment of differentiated thyroid carcinoma. World J Surg 21:546–551
Ghossein R (2009) Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin. Arch Pathol Lab Med 133:683–691
Ghossein R (2009) Update to the College of American Pathologists reporting on thyroid carcinomas. Head Neck Pathol 3:86–93
Ghossein R (2010) Encapsulated malignant follicular cell-derived thyroid tumors. Endocr Pathol 21:212–218
Ghossein RA, Rosai J, Heffess C (1997) Dyshormonogenetic goiter: A clinicopathologic study of 56 cases. Endocr Pathol 8:283–292
Ghossein RA, Hiltzik DH, Carlson DL, Patel S, Shaha A, Shah JP, Tuttle RM, Singh B (2006) Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer 106:1669–1676
Ghossein RA, Katabi N, Fagin JA (2013) Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancer along the spectrum of disease progression. J Clin Endocrinol Metab 98:E1414–1421
Gimm O, Krause U, Wessel H, Finke R, Dralle H (1997) Ectopic intrathyroidal thymus diagnosed as a solid thyroid lesion: case report and review of the literature. J Pediatr Surg 32:1241–1243
Gimm O, Morrisson CD, Suster S, Komminoth P, Mulligan L, Sweet KM (2004) Multiple endocrine neoplasia type 2. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (Hrsg) World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of Endocrine Organs. IARC Press, Lyon, S 211–217
Girelli ME, Nacamulli D, Pelizzo MR, De Vido D, Mian C, Piccolo M, Busnardo B (1998) Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986. Thyroid 8:517–523
Godbert Y, Henriques-Figueiredo B, Cazeau AL, Carrat X, Stegen M, Soubeyran I, Bonichon F (2013) A papillary thyroid microcarcinoma revealed by a single bone lesion with no poor prognostic factors. Case Rep Endocrinol 2013:719304
Goldsmith JD, Lai ML, Daniele GM, Tomaszewski JE, LiVolsi VA (2000) Amyloid goiter: report of two cases and review of the literature. Endocr Pract 6:318–323
Golshan MM, McHenry CR, de Vente J, Kalajyian RC, Hsu RM, Tomashefski JF (1997) Acute suppurative thyroiditis and necrosis of the thyroid gland: a rare endocrine manifestation of acquired immunodeficiency syndrome. Surgery 121:593–596
González-Cámpora R, Fuentes-Vaamonde E, Hevia-Vázquez A, Otal-Salaverri C, Villar-Rodriguez JL, Galera-Davidson H (1998) Hyalinizing trabecular carcinoma of the thyroid gland: report of two cases of follicular cell thyroid carcinoma with hyalinizing trabecular pattern. Ultrastruct Pathol 22:39–46
González-González A, Mate LA, Cabra JE (2008) Parasitic thyroid nodule in hashimoto’s thyroiditis. Endocrinol Nutr 55:301–303
Goffredo P, Cheung K, Roman SA, Sosa JA (2013) Can minimally invasive follicular thyroid cancer be approached as a benign lesion? A population-level analysis of survival among 1,200 patients. Ann Surg Oncol 20:767–772
Goh SG, Chuah KL, Goh HK, Chen YY (2003) Two cases of epithelioid angiosarcoma involving the thyroid and a brief review of non-Alpine epithelioid angiosarcoma of the thyroid. Arch Pathol Lab Med 127:70–73
Gordon G, Sparano BM, Kramer AW, Kelly RG, Iatropoulos MJ (1984) Thyroid gland pigmentation and minocycline therapy. Am J Pathol 117:98–109
Greco A, Miranda C, Pierotti MA (2010) Rearrangements of NTRK1 gene in papillary thyroid carcinoma. Mol Cell Endocrinol 321:44–49
Grüters-Kieslich A, Karges W, Schmid KW (2011) Kongenitale Schilddrüsenerkrankungen. In: Brabant G, Karges W (Kapitelkoordinatoren) Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. Thieme, Stuttgart, Sonderauszugsausgabe Schilddrüsenerkrankungen, S 6–12
Guyétant S, Josselin N, Savagner F, Rohmer V, Michalak S, Saint-André JP (2003) C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients. Mod Pathol 16:756–763
Harach HR (1985) Histological markers of solid cell nests of the thyroid. With some emphasis on their expression in thyroid ultimobranchial-related tumors. Acta Anat (Basel) 124:111–116
Harach HR, Franssila KO, Wasenius VM (1985) Occult papillary carcinoma of the thyroid. A ″normal″ finding in Finland. A systematic autopsy study. Cancer 56:531–538
Harach HR (1988) Solid cell nests of the thyroid. J Pathol 155:191–200
Harach HR, Bergholm U (1988) Medullary (C cell) carcinoma of the thyroid with features of follicular oxyphilic cell tumours. Histopathology 13:645–656
Harach HR, Williams ED (1990) The pathology of granulomatous diseases of the thyroid gland. Sarcoidosis 7:19–27
Harach HR, Bergholm U (1992) Small cell variant of medullary carcinoma of the thyroid with neuroblastoma-like features. Histopathology 21:378–380
Harach HR, Wilander E, Grimelius L, Bergholm U, Westermark P, Falkmer S (1992) Chromogranin A immunoreactivity compared with argyrophilia, calcitonin immunoreactivity, and amyloid as tumour markers in the histopathological diagnosis of medullary (C-cell) thyroid carcinoma. Pathol Res Pract 188:123–130
Harach HR, Bergholm U (1993) Medullary carcinoma of the thyroid with carcinoid-like features. J Clin Pathol 46:113–117
Harach HR (1997) Histogenesis of thyroid C-cell carcinoma. Curr Top Pathol 91:15–20
Harb WJ, Sturgis EM (2009) Differentiated thyroid cancer associated with intestinal polyposis syndromes: a review. Head Neck 31:1511–1519
Harrer P, Broecker M, Zint A, Schatz H, Zumtobel V, Derwahl M (1998) Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal. J Endocrinol Invest 21:380–385
Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ (1992) Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112:1139–1146
Haymart MR, Cayo M, Chen H (2009) Papillary thyroid microcarcinomas: big decisions for a small tumor. Ann Surg Oncol 16:3132–139
He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A (2005) The role of microRNA genes in papillary thyroid carcinoma. PNAS 102:19075–19080
Hegedüs L, Perrild H, Poulsen LR, Andersen JR, Holm B, Schnohr P, Jensen G, Hansen JM (1983) The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab 56:260–263
Hegedüs L, Karstrup S, Rasmussen N (1986) Evidence of cyclic alterations of thyroid size during the menstrual cycle in healthy women. Am J Obstet Gynecol 155:142–145
Hegerova L, Griebeler ML, Reynolds JP, Henry MR, Gharib H (2013) Metastasis to the Thyroid Gland: Report of a Large Series From the Mayo Clinic. Am J Clin Oncol (Epub ahead of print)
Hermann M, Tonninger K, Kober F, Furtlehner EM, Schultheis A, Neuhold N (2010) Minimal-invasives follikuläres Schilddrüsenkarzinom. Chirurg 81:627–635
Hillman N, Hardisson D, Herranz L, Martinez Olmos MA, Hernandez BJA, Nistal M, Pallardo LF (1997) Hürthle cell tumors. Ann Med Interne 148:434–439
Hirokawa M, Carney JA (2000) Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 24:575–578
Hofman V, Lassalle S, Bonnetaud C, Butori C, Loubatier C, Ilie M, Bordone O, Brest P, Guevara N, Santini J, Franc B, Hofman P (2009) Thyroid tumours of uncertain malignant potential: frequency and diagnostic reproducibility. Virchows Arch 455:21–33
Holm R, Sobrinho-Simões M, Nesland JM, Sambade C, Johannessen JV (1987) Medullary thyroid carcinoma with thyroglobulin immunoreactivity. A special entity? Lab Invest 57:258–268
Huang CC, Hsueh C, Liu FH, Chao TC, Lin JD (2011) Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas. Surg Oncol 20:1–6
Hunt JL, Baloch ZW, Barnes L, Swalsky PA, Trusky CL, Sesatomi E, Finkelstein S, LiVolsi VA (2002) Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis. Endocr Pathol 13:321–330
Hunt J (2005) Understanding the genotype of follicular thyroid tumors. Endocr Pathol 16:311–321
Huss LJ, Mendelsohn G (1990) Medullary carcinoma of the thyroid gland: an encapsulated variant resembling the hyalinizing trabecular (paraganglioma-like) adenoma of thyroid. Mod Pathol 3:581–585
Hussong JW, Perkins SL, Schnitzer B, Hargreaves H, Frizzera G (1999) Extramedullary plasmacytoma. A form of marginal zone cell lymphoma? Am J Clin Pathol 111:111–116
Ikeda T, Satoh M, Azuma K, Sawada N, Mori M (1998) Medullary thyroid carcinoma with a paraganglioma-like pattern and melanin production: a case report with ultrastructural and immunohistochemical studies. Arch Pathol Lab Med 122:555–558
Isaacson PG (1997) Lymphoma of the thyroid gland. Curr Top Pathol 91:1–14
Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2005) Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 29:917–920
Ito Y, Miyauchi A (2007) A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab 3:240–248
Iwasaki H, Matsumoto A, Ito K, Kure Y, Suzuki A, Sugino K, Ozaki O, Noh J (1990) Prediction of distant metastasis in follicular adenocarcinoma of the thyroid. World J Surg 14:425–429
Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I (2011) Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer 117:4439–4446
Iyer S, Bahn R (2012) Immunopathogenesis of Graves’ ophthalmopathy: the role of the TSH receptor. Best Pract Res Clin Endocrinol Metab 26:281–289
Janzer RC, Weber E, Hedinger C (1979) The relation between solid cell nests and C cells of the thyroid gland: an immunohistochemical and morphometric investigation. Cell Tissue Res 197:295–312
Jereczek-Fossa BA, Alterio D, Jassem J, Gibelli B, Tradati N, Orecchia R (2004) Radiotherapy-induced thyroid disorders. Cancer Treat Rev 30:369–384
Jochum W, Padberg BC, Schröder S (1994) Lymphoepitheliales Karzinom der Schilddrüse. Pathologe 15:361–365
Jones JD, Pittman DL, Sanders LR (1985) Necrosis of thyroid nodules after fine needle aspiration. Acta Cytol 29:29–32
Kahaly G, Dralle H, Mann K, Reiners C (2011) Autoimmunthyreopathien. In: Brabant G, Karges W (Kapitelkoordinatoren) Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. Thieme, Stuttgart, Sonderauszugsausgabe Schilddrüsenerkrankungen, S 12–22
Karger S, Weidinger C, Krause K, Sheu SY, Aigner T, Gimm O, Schmid KW, Dralle H, Führer D (2009) FOXO3a: a novel player in thyroid carcinogenesis? Endocr Relat Cancer 16:189–199
Karges W (2005) Klinische und molekulare Genetik des Schilddrüsenkarzinoms. Onkologe 11:20–28
Karges W (2010) Kalzitoninbestimmung zur Frühdiagnose des medullären Schilddrüsenkarzinoms. Chirurg 81:620–626
Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Vierhapper H, Haas OA, Niederle B (1998) C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 22:722–728
Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Haas OA, Vierhapper H, Niederle B (2001) Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol 25:1245–1251
Katoh R, Jasani B, Williams ED (1989) Hyalinizing trabecular adenoma of the thyroid. A report of three cases with immunohistochemical and ultrastructural studies. Histopathology 15:211–224
Kawahara E, Nakanishi I, Terahata S, Ikegaki S (1988) Leiomyosarcoma of the thyroid gland. A case report with a comparative study of five cases of anaplastic carcinoma. Cancer 62:2558–2563
Kim WG, Gong G, Kim EY, Kim TY, Hong SJ, Kim WB, Shong YK (2010) Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental. Clin Endocrinol (Oxf) 72:256–263
Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA (2003) High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454–1457
Kimura N, Nakazato Y, Nagura H, Sasano N (1990) Expression of intermediate filaments in neuroendocrine tumors. Arch Pathol Lab Med 114:506–510
Kodama T, Fujino M, Endo Y, Obara T, Fujimoto Y, Oda T, Wada T (1980) Identification of carcinoembryonic antigen in the C-cell of the normal thyroid. Cancer 45:98–101
Komminoth P (1997) The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clinical implications. Virchows Arch 431:1–9
Komorowski RA, Hanson GA (1988) Occult thyroid pathology in the young adult: an autopsy study of 138 patients without clinical thyroid disease. Hum Pathol 19:689–696
Koperek O, Scheuba C, Puri C, Birner P, Haslinger C, Rettig W, Niederle B, Kaserer K, Garin Chesa P (2007) Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma. Int J Oncol 31:59–67
Koperek O, Scheuba C, Cherenko M, Neuhold N, De Micco C, Schmid KW, Niederle B, Kaserer K (2008) Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential. Histopathology 52:623–630
Koperek O, Prinz A, Scheuba C, Niederle B, Kaserer K (2009) Tenascin C in medullary thyroid microcarcinoma and C-cell hyperplasia. Virchows Arch 455:43–48
Koperek O, Asari R, Niederle B, Kaserer K (2011) Desmoplastic stromal reaction in papillary thyroid microcarcinoma. Histopathology 58:919–924
Koperek O, Bergner O, Pichlhöfer B, Oberndorfer F, Hainfellner JA, Kaserer K, Horvat R, Harris AL, Niederle B, Birner P (2011) Expression of hypoxia-associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the VHL gene. J Pathol 225:63–72
Kovacs GL, Gonda G, Vadasz G, Ludmany E, Uhrin K, Gorombey Z, Kovacs L, Hubina E, Bodo M, Goth MI, Szabolcs I (2005) Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid 15:152–157
Krause K, Führer D (2008) Molekulare Mechanismen der Schilddrüsentumorgenese. Nuklearmediziner 31:209–215
Krisch K, Krisch I, Horvat G, Neuhold N, Ulrich W (1985) The value of immunohistochemistry in medullary thyroid carcinoma: a systematic study of 30 cases. Histopathology 9:1077–1089
Krohn K, Führer D, Holzapfel HP, Paschke R (1998) Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations. J Clin Endocrinol Metab 83:130–134
Krohn K, Paschke R (2002) Somatic mutations in thyroid nodular disease. Mol Genet Metab 75:202–208
Krohn K, Führer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, Paschke R (2005) Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 26:504–524
Krohn K, Maier J, Paschke R (2007) Mechanisms of disease: Hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors. Nat Clin Pract Endocrinol Metab 3:713–720
Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA (2000) PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma. Science 289:1357–1360
Kunavisarut T, Kak I, Macmillan C, Ralhan R, Walfish PG (2012) Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma. BMC Cancer 12:523
Kusada N, Hara Y, Kobayashi S, Weihua T, Nakamura Y, Kakudo K, Yuasa H (2005) A case of aggressive carcinoma showing thymus-like differentiation with distant metastases. Thyroid 15:1383–1388
Lam KY, Lo CY, Liu MC (2001) Primary squamous cell carcinoma of the thyroid gland: an entity with aggressive clinical behaviour and distinctive cytokeratin expression profiles. Histopathology 39:279–286
Lam AK, Lo CY (2006) Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution. Ann Surg Oncol 13:176–181
Landon G, Ordóñez NG (1985) Clear cell variant of medullary carcinoma of the thyroid. Hum Pathol 16:844–847
Lang W, Choritz H, Hundeshagen H (1986) Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol 10:246–255
Lang W, Borrusch H, Bauer L (1988) Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies. Am J Clin Pathol 90:72–76
Lazarus JH (1998) The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 8:909–913
Lee SL (2010) Complications of radioactive iodine treatment of thyroid carcinoma. J Natl Compr Canc Netw 8:1277–1286
Leenhardt L, Grosclaude P (2011) Épidémiologie des cancers thyroïdiens dans le monde. Ann Endocrinol 72:136–148
Lecuit M, Caumes E, Bricaire F, Gatineau M, Ménégaux F, Gentilini M (1995) Acute suppurative Salmonella enteritidis thyroiditis associated with thyrotoxicosis in a patient infected with the human immunodeficiency virus. Clin Infect Dis 20:196
Lemoine NR, Mayall ES, Wyllie FS, Williams ED, Goyns M, Stringer B, Wynford-Thomas D (1989) High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4:159–164
Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67
Lim DJ, Baek KH, Lee YS, Park WC, Kim MK, Kang MI, Jeon HM, Lee JM, Yun-Cha B, Lee KW, Son HY, Kang SK (2007) Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma. Thyroid 17:883–888
Lin JD, Hsueh C, Huang BY (2011) Papillary thyroid carcinoma with different histological patterns. Chang Gung Med J 34:23–34
Lin KD, Lin JD, Huang MJ, Huang HS, Jeng LB, Chao TC, Ho YS (1997) Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int Surg 82:378–381
Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, Tuttle RM, Ghossein RA (2006) Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107:1255–1264
Liu H, Singla A, Ao M, Gill RK, Venkatasubramanian J, Rao MC, Alrefai WA, Dudeja PK (2011) Calcitonin receptor-mediated CFTR activation in human intestinal epithelial cells. J Cell Mol Med 15:2697–2705
Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, Sun H, El-Naggar AK, Xing M (2013) Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer 20:603–610
LiVolsi VA, Merino MJ (1978) Squamous cells in the human thyroid gland. Am J Surg Pathol 2:133–140
LiVolsi VA (1990) Surgical Pathology of the Thyroid. Major Problems in Pathology Bd. 22. W.B. Saunders, Philadelphia
LiVolsi VA (1993) Current concepts in follicular tumors of the thyroid. Monogr Pathol 35:118–137
LiVolsi VA (2011) Papillary thyroid carcinoma: an update. Mod Pathol 24(2):1–9
LiVolsi VA, Abrosimov AA, Bogdanova T, Fadda G, Hunt JL, Ito M, Rosai J, Thomas GA, Williams ED (2011) The Chernobyl thyroid cancer experience: pathology. Clin Oncol (R Coll Radiol) 23:261–267
LiVolsi VA, Baloch ZW (2011) Follicular-patterned tumors of the thyroid: the battle of benign vs. malignant vs. so-called uncertain. Endocr Pathol 22:184–189
Ljungberg O, Ericsson UB, Bondeson L, Thorell J (1983) A compound follicular-parafollicular cell carcinoma of the thyroid: a new tumor entity? Cancer 52:1053–1061
Ljungberg O (1992) Biopsy pathology of the thyroid and parathyroid. Chapman & Hall, London, S 73–76
Lloyd RV, Sisson JC, Marangos PJ (1983) Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma. Cancer 51:2234–2239
Lloyd RV (1995) RET proto-oncogene mutations and rearrangements in endocrine diseases. Am J Pathol 147:1539–1544
Lloyd RV, Douglas BR, Young WF (2002) Thyroid Gland. In: Endocrine Diseases. Atlas of Nontumor Pathology AFIP, First Series, Fascicle, Bd. 1., S 91–169
Lloyd RV, Buehler D, Khanafshar E (2011) Papillary thyroid carcinoma variants. Head Neck Pathol 5:51–56
Lo CY, Lam KY, Wan KY (1999) Anaplastic carcinoma of the thyroid. Am J Surg 177:337–339
Lombardi CP, Bellantone R, De Crea C, Paladino NC, Fadda G, Salvatori M, Raffaelli M (2010) Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area. World J Surg 34:1214–1221
Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG, Sherman SI (2003) Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer 97:1186–1194
Lorenz K, Gimm O, Holzhausen HJ, Kittel S, Ukkat J, Thanh PN, Brauckhoff M, Dralle H (2007) Riedel’s thyroiditis: impact and strategy of a challenging surgery. Langenbecks Arch Surg 392:405–412
Lueblinghoff J, Eszlinger M, Jaeschke H, Mueller S, Bircan R, Gozu H, Sancak S, Akalin S, Paschke R (2011) Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations. Thyroid 21:221–229
Lugli A, Terracciano LM, Oberholzer M, Bubendorf L, Tornillo L (2004) Macrofollicular variant of papillary carcinoma of the thyroid: a histologic, cytologic, and immunohistochemical study of 3 cases and review of the literature. Arch Pathol Lab Med 128:54–58
Maceri DR, Babyak J, Ossakow SJ (1986) Lateral neck mass. Sole presenting sign of metastatic thyroid cancer. Arch Otolaryngol Head Neck Surg 112:47–49
Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD, Wahl RA, Lamesch P, Raue F, Conte-Devolx B, Dralle H (2003) European Multiple Endocrine Neoplasia (EUROMEN) Study Group. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517–1525
Machens A, Holzhausen HJ, Dralle H (2005) The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 103:2269–2273
Machens A, Dralle H (2006) Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside. Mol Cell Endocrinol 247:34–40
Magnata Filho LA, Bordallo MA, Pessoa CH, Corbo R, Bulzico DA, Dias FL, Machado AL, Soares AB, Ferman S (2010) Thyroid spindle epithelial tumor with thymus-like differentiation (SETTLE): case report and review. Arq Bras Endocrinol Metabol 54:657–662
Magro G, Grasso S (2000) Sustentacular cells in sporadic paraganglioma-like medullary thyroid carcinoma: Report of a case with diagnostic and histogenetic considerations. Pathol Res Pract 196:55–59
Manson CM, Cross P, De Sousa B (1992) Post-operative necrotizing granulomas of the thyroid. Histopathology 21:392–393
Marcus JN, Dise CA, LiVolsi VA (1982) Melanin production in a medullary thyroid carcinoma. Cancer 49:2518–2526
Martin JM, Randhawa G, Temple WJ (1986) Cervical thymoma. Arch Pathol Lab Med 110:354–357
Martinez F, Filipowicz E, Hudnall SD (2002) Plasma cell granuloma of the thyroid. Arch Pathol Lab Med 126:595–598
Martino E, Bartalena L, Bogazzi F, Braverman LE (2001) The effects of amiodarone on the thyroid. Endocr Rev 22:240–254
Martino F, Avila LF, Encinas JL, Luis AL, Olivares P, Lassaletta L, Nistal M, Tovar JA (2006) Teratomas of the neck and mediastinum in children. Pediatr Surg Int 22:627–634
Martins T, Carrilho F, Gomes L, Mesquita C, Martins MJ, Carvalheiro M (2006) Malignant teratoma of the thyroid: case report. Thyroid 16:1311–1313
Matias-Guiu X, Caixas A, Costa I, Cabezas R, Prat J (1994) Compound medullary-papillary carcinoma of the thyroid: true mixed versus collision tumour [corrected]. Histopathology 25:183–185
Matias-Guiu X, Machin P, Pons C, Lagarda E, De Leiva A, Prat J (1998) Sustentacular cells occur frequently in the familial form of medullary thyroid carcinoma. J Pathol 184:420–423
Máximo V, Sobrinho-Simões M (2000) Hurthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch 437:107–115
Máximo V, Botelho T, Capela J, Soares P, Lima J, Taveira A, Amaro T, Barbosa AP, Preto A, Harach HR, Williams D, Sobrinho-Simões M (2005) Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer 92:1892–1898
Máximo V, Soares P, Sobrinho Simoes M (2009) Mitochondria and cancer. Virchows Arch 454:481–495
Máximo V, Lima J, Prazeres H, Soares P, Sobrinho-Simões M (2012) The biology and the genetics of Hurthle cell tumors of the thyroid. Endocr Relat Cancer 19:131–147
McCluggage WG, Sloan JM (1996) Hyalinizing trabecular carcinoma of thyroid gland. Histopathology 28:357–362
McLachlan SM, Prummel MF, Rapoport B (1994) Cell-mediated or humoral immunity in Graves’ ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue. J Clin Endocrinol Metab 78:1070–1074
McLachlan SM, Rapoport B (2013) Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid 23:14–24
McNicol AM, Lewis (1996) The thyroid gland. In: Lewis (Hrsg) The endocrine system. Systemic pathology, Bd. 12. Churchill Livingstone, New York, S 131–185
Mendelsohn G (1984) Signet-cell-simulating microfollicular adenoma of the thyroid. Am J Surg Pathol 8:705–708
Menon MP, Khan A (2009) Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications. J Clin Pathol 62:978–985
Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, Gardini G, Valcavi R, Barbieri V (2009) Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19:707–716
Mete OASL (2011) Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 24:1545–1552
Michalek K, Morshed SA, Latif R, Davies TF (2009) TSH receptor autoantibodies. Autoimmun Rev 9:113–116
Mills SEAMS Jr (1986) Congenital occult papillary carcinoma of the thyroid gland. Hum Pathol 17:1179–1181
Mizukami Y, Nonomura A, Michigishi T, Noguchi M, Hashimoto T, Nakamura S, Ishizaki T (1994) Solid cell nests of the thyroid. A histologic and immunohistochemical study. Am J Clin Pathol 101:186–191
Mizukami Y, Michigishi T, Nonomura A, Nakamura S, Noguchi M, Takazakura E (1995) Histological features of the thyroid gland in a patient with lithium induced thyrotoxicosis. J Clin Pathol 48:582–584
Molberg K, Albores-Saavedra J (1994) Hyalinizing trabecular carcinoma of the thyroid gland. Hum Pathol 25:192–197
Motamed M, McGlashan JA (2004) Thyroglossal duct carcinoma. Curr Opin Otolaryngol Head Neck Surg 12:106–109
Montone KT, Baloch ZW, LiVolsi VA (2008) The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med 132:1241–1250
Moreno A, Rodriguez JM, Sola J, Soria T, Parrilla P (1996) Encapsulated papillary neoplasm of the thyroid: retrospective clinicopathological study with long term follow up. Eur J Surg 162:177–180
Murugan AK, Xing M (2011) Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene. Cancer Res 71:4403-4411
Musholt PB, Musholt TJ, Morgenstern SC, Worm K, Sheu SY, Schmid KW (2008) Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot. World J Surg 32:722–728
Musholt TJ, Musholt PB, Khaladj N, Schulz D, Scheumann GF, Klempnauer J (2000) Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma. Surgery 128:984–993
Musholt TJ, Musholt PB, Petrich T, Oetting G, Knapp WH, Klempnauer J (2000) Familial papillary thyroid carcinoma: genetics, criteria for diagno-sis, clinical features, and surgical treatment. World J Surg 24:1409–1417
Musholt TJ, Brehm C, Hanack J, von Wasielewski R, Musholt PB (2006) Identification of differentially expressed genes in papillary thyroid carcinomas with and without rearrangements of the tyrosine kinase receptors RET and/or NTRK1. J Surg Res 131:15–25
Musholt TJ, Clerici T, Dralle H, Frilling A, Goretzki PE, Hermann MM, Kussmann J, Lorenz K, Nies C, Schabram J, Schabram P, Scheuba C, Simon D, Steinmüller T, Trupka AW, Wahl RA, Zielke A, Bockisch A, Karges W, Luster M, Schmid KW, Interdisciplinary Task Force Guidelines of the German Association of Endocrine Surgeons (2011) German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease. Langenbecks Arch Surg 396:639–649
Nadig J, Weber E, Hedinger C (1978) C-cell in vestiges of the ultimobranchial body in human thyroid glands. Virchows Arch B Cell Pathol 27:189–191
Nakachi K, Hayashi T, Hamatani K, Eguchi H, Kusunoki Y (2008) Sixty years of follow-up of Hiroshima and Nagasaki survivors: current progress in molecular epidemiology studies. Mutat Res 659:109–117
Nakazawa T, Cameselle-Teijeiro J, Vinagre J, Soares P, Rousseau E, Eloy C, Sobrinho-Simões M (2014) C-cell-derived calcitonin-free neuroendocrine carcinoma of the thyroid: the diagnostic importance of CGRP immunoreactivity. Int J Surg Pathol 22:530–535
Nesland JM, Sobrinho-Simões MA, Holm R, Sambade MC, Johannessen JV (1985) Hürthle-cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry. Ultrastruct Pathol 8:269–290
Neuhold N, Kaiser H, Kaserer K (2001) Latent carcinoma of the thyroid in Austria: a systematic autopsy study. Endocr Pathol 12:23–31
Neuhold N, Schultheis A, Hermann M, Krotla G, Koperek O, Birner P (2011) Incidental papillary microcarcinoma of the thyroid – further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up. Ann Surg Oncol 18:3430–3436
Niemeier LA, Kuffner Akatsu H, Song C, Carty SE, Hodak SP, Yip L, Ferris RL, Tseng GC, Seethala RR, Lebeau SO, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforov YE (2012) A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. Cancer 118:2069–2077
Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV (2001) Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol 25:1478–1484
Nikiforov YE (2002) RET/PTC rearrangement in thyroid tumors. Endocr Pathol 13:3–16
Nikiforov YE (2011) Molecular analysis of thyroid tumors. Mod Pathol 2:34–43
Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE (2003) BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399–5404
Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW 2nd, Tallini G, Kroll TG, Nikiforov YE (2003) RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318–2326
Nikiforova MN, Nikiforov YE (2008) Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Expert Rev Mol Diagn 8:83–95
Ning S, Song X, Xiang L, Chen Y, Cheng Y, Chen H (2011) Malignant solitary fibrous tumor of the thyroid gland: report of a case and review of the literature. Diagn Cytopathol 39:694–699
Nosé V (2011) Familial thyroid cancer: a review. Mod Pathol 24 Suppl 2:19–33
O’Neill CJ, Vaughan L, Learoyd DL, Sidhu SB, Delbridge LW, Sywak MS (2011) Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol 37:181–185
Ottino A, Pianzola HM, Castelletto RH (1989) Occult papillary thyroid carcinoma at autopsy in La Plata, Argentina. Cancer 64:547–551
Ozaki O, Ito K, Mimura T, Sugino K, Hosoda Y (1996) Papillary carcinoma of the thyroid. Tall-cell variant with extensive lymphocyte infiltration. Am J Surg Pathol 20:695–698
Ozdemir D, Dagdelen S, Erbas T (2010) Endocrine involvement in systemic amyloidosis. Endocr Pract 16:1056–1063
Ozkara SK, Gürbüz Y, Müezzinoğlu B, Yumbal Z (2002) Encapsulated cystic papillary variant of medullary carcinoma of thyroid gland. Endocr Pathol 13:167–171
Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, Croce CM, Fusco A (2006) MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13:497–508
Pallante P, Visone R, Croce CM, Fusco A (2010) Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer 17:91–104
Palos-Paz F, Perez-Guerra O, Cameselle-Teijeiro J, Rueda-Chimeno C, Barreiro-Morandeira F, Lado-Abeal J (2008) Galician Group for the Study of Toxic Multinodular Goitre, Araujo Vilar D, Argueso R, Barca O, Botana M, Cabezas-Agrícola JM, Catalina P, Dominguez Gerpe L, Fernandez T, Mato A, Nuño A, Penin M, Victoria B. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. Eur J Endocrinol 159:623–631
Papi G, Corrado S, Cesinaro AM, Novelli L, Smerieri A, Carapezzi C (2002) Riedel’s thyroiditis: clinical, pathological and imaging features. Int J Clin Pract 56:65–67
Papi G, LiVolsi V (2004) Current concepts on Riedel Thyreoiditis. Am J Clin Pathol 121:50–S63
Papi G, Corrado S, Uberti ED, Roti E (2007) Solitary fibrous tumor of the thyroid gland. Thyroid 17:119–126
Papotti M, Negro F, Carney JA, Bussolati G, Lloyd RV (1997) Mixed medullary-follicular carcinoma of the thyroid. A morphological, immunohistochemical and in situ hybridization analysis of 11 cases. Virchows Arch 430:397–405
Papotti M, Riella P, Montemurro F, Pietribiasi F, Bussolati G (1997) Immunophenotypic heterogeneity of hyalinizing trabecular tumours of the thyroid. Histopathology 31:525–533
Papotti M, Manazza AD, Chiarle R, Bussolati G (2004) Confocal microscope analysis and tridimensional reconstruction of papillary thyroid carcinoma nuclei. Virchows Arch 444:350–355
Papotti M, Arrondini M, Tavaglione V, Veltri A, Volante M (2008) Diagnostic controversies in vascular proliferations of the thyroid gland. Endocr Pathol 19:175–183
Park CS, Min JS (1989) Lateral neck mass as the initial manifestation of thyroid carcinoma. Head Neck 11:410–413
Paschke R, Ludgate M (1997) The thyrotropin receptor in thyroid diseases. N Engl J Med 337:1675–1681
Paschke R, Brabant G, Dralle H, Reiners C (2011) Struma diffusa und Knotenstruma. In: Brabant G, Karges W (Kapitelkoordinatoren) Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. Thieme, Stuttgart, Sonderauszugsausgabe Schilddrüsenerkrankungen, S 22–28
Patten DK, Wani Z, Tolley N (2012) Solitary Langerhans histiocytosis of the thyroid gland: a case report and literature review. Head Neck Pathol 6:279–289
Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A (2004) Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89:3713–3720
Pellegriti G, Lumera G, Malandrino P, Latina A, Masucci R, Scollo C, Spadaro A, Sapuppo G, Regalbuto C, Pezzino V, Vigneri R (2013) Thyroid cancer in thyroglossal duct cysts requires a specific approach due to its unpredictable extension. J Clin Endocrinol Metab 98:458–465
Peretz A, Leiberman E, Kapelushnik J, Hershkovitz E (2004) Thyroglossal duct carcinoma in children: case presentation and review of the literature. Thyroid 14:777–785
Perry A, Molberg K, Albores-Saavedra J (1996) Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities. Cancer 77:750–756
Piana S, Ragazzi M, Tallini G, de Biase D, Ciarrocchi A, Frasoldati A, Rosai J (2013) Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis. Hum Pathol 44:556–565
Pichardo-Lowden A, Durvesh S, Douglas S, Todd W, Bruno M, Goldenberg D (2009) Anaplastic thyroid carcinoma in a young woman: a rare case of survival. Thyroid 19:775–779
Piehl S, Hoefig CS, Scanlan TS, Köhrle J (2011) Thyronamines – past, present, and future. Endocr Rev 32:64–80
Pilarsky R (2009) Cowden Syndrome: a critical review of the clinical literature. J Gent Counsel 18:13–27
Pilotti S, Collini P, Mariani L, Placucci M, Bongarzone I, Vigneri P, Cipriani S, Falcetta F, Miceli R, Pierotti MA, Rilke F (1997) Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland. Am J Surg Pathol 21:1466–1473
Ponder BAJ (2002) Multiple endocrine neoplasia type 2. In: Vogelstein B, Kinzler KW (Hrsg) The genetic basis of human cancer, 2. Aufl. McGraw-Hill, New York, S 501–513
Pritchyk K, Newkirk K, Garlich P, Deeb Z (2004) Tamoxifen therapy for Riedel’s thyroiditis. Laryngoscope 114:1758–1760
Quadbeck B, Eckstein AK, Tews S, Walz M, Hoermann R, Mann K, Gieseler R (2002) Maturation of thyroidal dendritic cells in Graves’ disease. Scand J Immunol 55:612–620
Rambaud JC, Jian R, Flourié B, Hautefeuille M, Salmeron M, Thuillier F, Ruskoné A, Florent C, Chaoui F, Bernier JJ (1988) Pathophysiological study of diarrhoea in a patient with medullary thyroid carcinoma. Evidence against a secretory mechanism and for the role of shortened colonic transit time. Gut 29:537–543
Ramp U, Pfitzer P, Gabbert HE (1995) Fine needle aspiration (FNA)-induced necrosis of tumours of the thyroid. Cytopathology 6:248–254
Raue F, Frank-Raue K (2009) Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management. Hormones (Athens) 8:23–28
Regensburg NI, Wiersinga WM, Berendschot TT, Potgieser P, Mourits MP (2011) Do subtypes of Graves’ orbitopathy exist? Ophthalmol 118:191–196
Reid JD, Choi CH, Oldroyd NO (1987) Calcium oxalate crystals in the thyroid. Their identification, prevalence, origin, and possible significance. Am J Clin Pathol 87:443–454
Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R, Schumm-Draeger PM (2004) Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 14:926–932
Reiners C, Paschke R, Mann K (2011) Funktionelle Autonomie. In: Brabant G, Karges W (Kapitelkoordinatoren) Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. Thieme, Stuttgart, Sonderauszugsausgabe Schilddrüsenerkrankungen, S 28–30
Reis-Filho JS, Preto A, Soares P, Ricardo S, Cameselle-Teijeiro J, Sobrinho-Simões (2003) p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Mod Pathol 16:43–48
Ricarte-Filho JC, Ryder M, Chitale DA, Rivera M, Heguy A, Ladanyi M, Janakiraman M, Solit D, Knauf JA, Tuttle RM, Ghossein RA, Fagin JA (2009) Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Res 69:4885–4893
Riedlinger WF, Lack EE, Robson CD, Rahbar R, Nose V (2005) Primary thyroid teratomas in children: a report of 11 cases with a propsal of criteria for their diagnosis. Am J Surg Pathol 29:700–706
Rigaud C, Peltier F, Bogomoletz WV (1985) Mucin producing microfollicular adenoma of the thyroid. J Clin Pathol 38:277–280
Rivera M, Tuttle RM, Patel S, Shaha A, Shah JP, Ghossein RA (2009) Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid 19:119–127
Rivera M, Ricarte-Filho J, Patel S, Tuttle M, Shaha A, Shah JP, Fagin JA, Ghossein RA (2010) Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol 41:172–180
Rocha AS, Soares P, Machado JC, Máximo V, Fonseca E, Franssila K, Sobrinho-Simões M (2002) Mucoepidermiod carcinoma of the thyroid: a tumour histotype characterized by P-caherin neoexpression and marked abnormalities of the E-cadherin/catenins complex. Virchows Arch 440:498–504
Rodriguez I, Ayala E, Caballero C, De Miguel C, Matias-Guiu X, Cubilla AL, Rosai J (2001) Solitary fibrous tumor of the thyroid gland: report of seven cases. Am J Surg Pathol 25:1424–1428
Roka S, Kornek G, Schüller J, Ortmann E, Feichtinger J, Armbruster C (2004) Carcinoma showing thymic-like elements – a rare malignancy of the thyroid gland. Br J Surg 91:142–145
Rosai J, Saxén EA, Woolner L (1985) Undifferentiated and poorly differentiated carcinoma. Semin Diagn Pathol 2:123–136
Rosai J, Carcangiu ML, DeLellis RA (1992) Tumors of the Thyroid Gland. Atlas of Tumor Pathology AFIP, Third Series, Bd. 5. Armed Forces Institute of Pathology, Washington, D.C
Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED (2003) Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol 11:249–251
Rosai J (2005) Handling of thyroid follicular patterned lesions. Endocr Pathol 16:279–283
Rothenberg HJ, Goellner JR, Carney JA (1999) Hyalinizing trabecular adenoma of the thyroid gland: recognition and characterization of its cytoplasmic yellow body. Am J Surg Pathol 23:118–125
Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio MR, Busutti L, Pearce EN, Braverman LE, Degli Uberti EC (2006) Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab 91:2171–2178
Roti E, degli Uberti EC, Bondanelli M, Braverman LE (2008) Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol 159:659–673
Rufini V, Salvatori M, Fadda G, Pinnarelli L, Castaldi P, Maussier ML, Galli G (2007) Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns. Cancer 110:1209–1217
Russo D, Arturi F, Schlumberger M, Caillou B, Monier R, Filetti S, Suárez HG (1995) Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene 11:1907–1911
Ryska A, Vokurka J, Michal M, Ludvíková M (1997) Intrathyroidal lymphoepithelial cyst. A report of two cases not associated with Hashimoto’s thyroiditis. Pathol Res Pract 193:777–781
Ryska A, Ludvíková M, Rydlová M, Cáp J, Zalud R (2006) Massive squamous metaplasia of the thyroid gland - report of three cases. Pathol Res Pract 202:99–106
Sadow PM, Hunt JL (2010) Mixed Medullary-follicular-derived carcinomas of the thyroid gland. Adv Anat Pathol 17:282–285
Saggiorato E, Rapa I, Garino F, Bussolati G, Orlandi F, Papotti M, Volante M (2007) Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia. J Mol Diagn 9:214–219
Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52:1849–1855
Salajegheh A, Petcu EB, Smith RA, Lam AK (2008) Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists. Postgrad Med J 84:78–82
Salvatore G, Chiappetta G, Nikiforov YE et al (2005) Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations. Eur J Cancer 41:816–821
Sambade C, Baldaque-Faria A, Cardoso-Oliveira M, Sobrinho-Simões M (1988) Follicular and papillary variants of medullary carcinoma of the thyroid. Pathol Res Pract 184:98–107
Sampson RJ, Key CR, Buncher CR, Iijima S (1971) Smallest forms of papillary carcinoma of the thyroid. A study of 141 microcarcinomas less than 0.1 cm in greatest dimension. Arch Pathol 91:334–339
Sampson RJ, Woolner LB, Bahn RC, Kurland LT (1974) Occult thyroid carcinoma in Olmsted County, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer 34:2072–2076
Santeusanio G, Schiaroli S, Ortenzi A, Mulè A, Perrone G, Fadda G (2008) Solitary fibrous tumour of thyroid: report of two cases with immunohistochemical features and literature review. Head Neck Pathol 2:231–235
Sargent R, LiVolsi V, Murphy J, Mantha G, Hunt JL (2006) BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis. Endocr Pathol 17:235–241
Satge D, Grob JC, Pusel J, Methlin G (1990) [Thyroid microcarcinoma with a fatal outcome and 34 other unusually aggressive cases reported in the literature]. Arch Anat Cytol Pathol 38:143–151
Scheuba C, Kaserer K, Weinhäusl A, Pandev R, Kaider A, Passler C, Prager G, Vierhapper H, Haas OA, Niederle B (1999) Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery 126:1089–1095
Scheuba C, Kaserer K, Kotzmann H, Bieglmayer C, Niederle B, Vierhapper H (2000) Prevalence of C-cell hyperplasia in patients with normal basal and pentagastrin-stimulated calcitonin. Thyroid 10:413–416
Scheuba C, Kaserer K, Kaczirek K, Asari R, Niederle B (2006) Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative ″marker″ for lymph node metastases. World J Surg 30:853–859
Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338:297–306
Schmid KW, Hofstädter F (1984) Thymic inclusion in the thyroid gland of a premature birth of the 36th week of gestation. Acta Anat 120:65
Schmid KW, Fischer-Colbrie R, Hagn C, Jasani B, Williams ED, Winkler H (1987) Chromogranin A and B and secretogranin II in medullary carcinomas of the thyroid. Am J Surg Pathol 11:551–556
Schmid KW, Tötsch M, Hittmair A, Feichtinger H, Ladurner D, Hofstädter F (1989) Frequency of medullary thyroid carcinoma in an endemic goiter area. Mod Pathol 2:90–93
Schmid KW, Hittmair A, Ofner C, Tötsch M, Ladurner D (1991) Metastatic tumors in fine needle aspiration biopsy of the thyroid. Acta Cytol 35:722–724
Schmid KW, Kirchmair R, Ladurner D, Fischer-Colbrie R, Böcker W (1992) Immunohistochemical comparison of chromogranins A and B and secretogranin II with calcitonin and calcitonin gene-related peptide expression in normal, hyperplastic and neoplastic C-cells of the human thyroid. Histopathology 21:225–232
Schmid KW (1993) Subacute granulomatous (deQuervain´s) thyroiditis. Am Soc Clin Pathol, Check Sample Continuing Education Program AP 93-7: 1–4
Schmid KW, Böcker W (1993) Medulläres Schilddrüsenkarzinom. Immunhistochemische Marker in Histopathololgie und Forschung. Zentralbl Pathol 139:115–129
Schmid KW, Morgan JM, Baumert M, Fischer-Colbrie R, Böcker W, Jasani B (1995) Calcitonin and calcitonin gene-related peptide mRNA detection in a population of hyperplastic parathyroid cells also expressing chromogranin B. Lab Invest 73:90–95
Schmid KW, Tötsch M, Öfner D, Böcker W, Ladurner D (1997) Minimally invasive follicular thyroid carcinoma: a clinico-pathological study. Curr Top Pathol 91:37–43
Schmid KW, Ensinger C (1998) Atypical″ medullary thyroid carcinoma with little or no calcitonin expression. Virchows Arch 433:209–215
Schmid KW, Sheu SY, Görges R, Ensinger C, Tötsch M (2003) Tumoren der Schilddrüse. Pathologe 24:357–372
Schmid KWWC (2003) Die missglückte Klassifikation. Pathologe 24:338
Schmid KW, Farid NR (2006) How to define follicular thyroid carcinoma? Virchows Arch 448:385–393
Schmid KW (2010) Pathogenese, Klassifikation und Histologie von Schilddrüsenkarzinomen. Onkologe 16:644–656
Schmid KW, Ting S, Sheu SY (2010) Familiäre Karzinome der Schilddrüse. Pathologe 31:485–488
Schmitz KJ, Baumgaertel MW, Schmidt C, Sheu SY, Betzler M, Schmid KW (2008) Wegener’s granulomatosis in the thyroid mimicking a tumour. Virchows Arch 452:571–574
Schröder S, Böcker W, Dralle H, Kortmann KB, Stern C (1984) The encapsulated papillary carcinoma of the thyroid. A morphologic subtype of the papillary thyroid carcinoma. Cancer 54:90–93
Schröder S, Böcker W, Hüsselmann H, Dralle H (1984) Adenolipoma (thyrolipoma) of the thyroid gland report of two cases and review of literature. Virchows Arch A Pathol Anat Histopathol 404:99–103
Schröder S, Hüsselmann H, Böcker W (1984) Lipid-rich cell adenoma of the thyroid gland. Report of a peculiar thyroid tumour. Virchows Arch A Pathol Anat Histopathol 404:105–108
Schröder S, Klöppel G (1987) Carcinoembryonic antigen and nonspecific cross-reacting antigen in thyroid cancer. An immunocytochemical study using polyclonal and monoclonal antibodies. Am J Surg Pathol 11:100–108
Schröder S, Böcker W, Baisch H, Bürk CG, Arps H, Meiners I, Kastendieck H, Heitz PU, Klöppel G (1988) Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content. Cancer 61:806–816
Schwertheim S, Sheu SY, Worm K, Grabellus F, Schmid KW (2009) Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma. Hormone and Metabolic Research 41:475–481
Serra SASL (2008) Controversies in thyroid pathology: the diagnosis of follicular neoplasms. Endocr Pathol 19:156–165
Shahi N, Abdelhamid MF, Jindall M, Awad RW (2010) Riedel’s thyroiditis masquerading as anaplastic thyroid carcinoma: a case report. J Med Case Rep 4:15
Sheu SY, Schmid KW (2003) Entzündliche Schilddrüsenerkrankungen. Epidemiologie, Klinik und Morphologie. Pathologe 24:339–347
Sheu SY, Görges R, Schmid KW (2003) Hyperplasien der Schilddrüse. Pathologe 24:348–356
Sheu SY, Wenzel RR, Kersting C, Merten R, Otterbach F, Schmid KW (2004) Erdheim-Chester disease: case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literature. J Clin Pathol 57:1225–1228
Sheu SY, Frilling A, Betzler M, Peitsch W, Schmid KW (2005) Der intraoperative Gefrierschnitt von Schilddrüsenknoten. lndikation - Verlässlichkeit - Grenzen. Viszeralchirurgie 40:174–179
Sheu SY, Levin S, Schmid KW (2006) Therapiebedingte Veränderungen der Schilddrüse. Pathologe 27:13–18
Sheu SY, Schwertheim S, Worm K, Grabellus F, Schmid KW (2007) Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements. Mod Pathol 20:779–787
Sheu SY, Grabellus F, Schwertheim S, Handke S, Worm K, Schmid KW (2009) Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma. Horm Metab Res 41:482–487
Sheu SY, Vogel E, Worm K, Grabellus F, Schwertheim S, Schmid KW (2010) Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma. Histopathology 56:632–640
Sheu SY, Grabellus F, Schwertheim S, Worm K, Broecker-Preuss M, Schmid KW (2010) Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer 102:376–382
Sheu SY, Schmid KW (2010) Multiple endocrine Neoplasien Typ 2. Pathologe 31:449–454 (Erratum Pathologe (2011) 32: 82)
Shimizu M, Hirokawa M, Manabe T (1999) Parasitic nodule of the thyroid in a patient with Graves’ disease. Virchows Arch 434:241–244
Singh K, Sharma MC, Jain D, Kumar R (2008) Melanotic medullary carcinoma of thyroid--report of a rare case with brief review of literature. Diagn Pathol 3:2
Sippel RS, Caron NR, Clark OH (2007) An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 31:924–933
Skacel M, Ross CW, Hsi ED (2000) A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma. Histopathology 37:10–18
Sneed DC (1999) Protocol for the examination of specimens from patients with malignant tumors of the thyroid gland, exclusive of lymphomas. Arch Pathol Lab Med 123:45–49
Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Máximo V, Botelho T, Seruca R, Sobrinho-Simões M (2003) BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22:4578–4580
Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Máximo V, Sobrinho-Simões M (2011) Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Curr Genomics 12:609–617
Sobin LH, Gospodarowicz M, Wittekind C (2009) TNM Classification of Malignant Tumours, 7. Aufl. Wiley-Liss, New York, S 58–62
Sobrinho-Simoes MA, Sambade MC, Goncalves V (1979) Latent thyroid carcinoma at autopsy. Cancer 43:1702–1706
Sobrinho-Simões M, Preto A, Rocha AS, Castro P, Máximo V, Fonseca E, Soares P (2005) Molecular pathology of well-differentiated thyroid carcinomas. Virchows Arch 447:787–793
Sobrinho-Simões M, Máximo V, Rocha AS, Trovisco V, Castro P, Preto A, Lima J, Soares P (2008) Intragenic mutations in thyroid cancer. Endocrinol Metab Clin North Am 37:333–362
Sobrinho-Simões M, Eloy C, Magalhães J, Lobo C, Amaro T (2011) Follicular thyroid carcinoma. Mod Pathol 2:10–18
Song Z, Yu C, Song X, Wei L, Liu A (2011) Primary solitary fibrous tumor of the thyroid - report of a case and review of the literature. J Cancer 2:206–209
Spires JR, Schwartz MR, Miller RH (1988) Anaplastic thyroid carcinoma. Association with differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 114:40–44
Stein SA, Wartofsky L (2013) Primary Thyroid Lymphoma: A Clinical Review. J Clin Endocrinol Metab 98:3131–3138
Stocker DJ, Burch HB (2003) Thyroid cancer yield in patients with Graves’ disease. Minerva Endocrinol 28:205–212
Stratakis CA, Courcoutsakis NA, Abati A, Filie A, Doppman JL, Carney JA, Shawker T (1997) Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab 82:2037–2043
Sugino K, Ito K Jr, Ozaki O, Mimura T, Iwasaki H, Ito K (1998) Papillary microcarcinoma of the thyroid. J Endocrinol Invest 21:445–448
Sugitani I, Yanagisawa A, Shimizu A, Kato M, Fujimoto Y (1998) Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg 22:731–737
Syed MI, Stewart M, Syed S, Dahill S, Adams C, McLellan DR, Clark LJ (2011) Squamous cell carcinoma of the thyroid gland: primary or secondary disease? J Laryngol Otol 125:3–9
Takeda M, Mikami T, Numata Y, Okamoto M, Okayasu I (2013) Papillary thyroid carcinoma with heterotopic ossification is a special subtype with extensive progression. Am J Clin Pathol 139:587–598
Tallini G, Santoro M, Helie M, Carlomagno F, Salvatore G, Chiappetta G, Carcangiu ML, Fusco A (1998) RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res 4:287–294
Tanboon J, Keskool P (2013) Leiomyosarcoma: A rare tumor of the thyroid. Endocr Pathol 24:126–143
Taweevisit M, Sampatanukul P, Thorner PS (2013) Ectopic thymoma can mimic benign and malignant thyroid lesions on fine needle aspiration cytology: a case report and literature review. Acta Cytol 57:213–220
Tetzlaff MT, Liu A, Xu X, Master SR, Baldwin DA, Tobias JW, Livolsi VA, Baloch ZW (2007) Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocrine Pathology 18:163–173
Ting S, Puttinger C, Schmid KW, Sheu-Grabellus SY (2012) Der hyalinisierende trabekuläre Tumor der Schilddrüse. Eine übertrieben vorsichtige Bezeichnung für einen gutartigen Tumor? Pathologe 33:135–141
Thompson LD, Wenig BM, Adair CF, Heffess CS (1996) Peripheral Nerve Sheath Tumors of the Thyroid Gland: A Series of Four Cases and a Review of the Literature. Endocr Pathol 7:309–318
Thompson LD, Wenig BM, Adair CF, Shmookler BM, Heffess CS (1997) Primary smooth muscle tumors of the thyroid gland. Cancer 79:579–587
Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS (2001) A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer 91:505–524
Torres-Montaner A, Beltrán M, de la Romero Osa A, Oliva H (2001) Sarcoma of the thyroid region mimicking Riedel’s thyroiditis. J Clin Pathol 54:570–572
Tóth K, Péter I, Kremmer T, Sugár J (1990) Lipid-rich cell thyroid adenoma: histopathology with comparative lipid analysis. Virchows Arch A Pathol Anat Histopathol 417:273–276
Trovisco V, de Vieira Castro I, Soares P, Máximo V, Silva P, Magalhães J, Abrosimov A, Guiu XM, Sobrinho-Simões M (2004) BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol 202:247–251
Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, Caillou B, Travagli JP, Parmentier C (1985) Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794–804
Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481–493
Ueki I, Ando T, Haraguchi A, Horie I, Imaizumi M, Hayashi T, Uga T, Usa T, Kawakami A (2011) A case of mixed medullary and follicular cell carcinoma of the thyroid. Intern Med 50:1313–1316
Uribe M, Fenoglio-Preiser CM, Grimes M, Feind C (1985) Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature. Am J Surg Pathol 9:577–594
van Heerden JA, Hay ID, Goellner JR, Salomao D, Ebersold JR, Bergstralh EJ, Grant CS (1992) Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery 112:1130–1136
Vantyghem MC, Pigny P, Leteurtre E, Leclerc L, Bauters C, Douillard C, D’Herbomez M, Carnaille B, Proye C, Wemeau JL, Lecomte-Houcke M (2204) Thyroid carcinomas involving follicular and parafollicular C cells: seventeen cases with characterization of RET oncogenic activation. Thyroid 14:842–847
Vaidya B, Harris PE, Barrett P, Kendall-Taylor P (1997) Corticosteroid therapy in Riedel’s thyroiditis. Postgrad Med J 73:817–819
Vailati A, Marena C, Aristia L, Sozzé E, Barosi G, Inglese V, Luisetti M, Bossolo PA (1993) Sarcoidosis of the thyroid: report of a case and a review of the literature. Sarcoidosis 10:66–68
Vargas PA, Bernardi FD, Alves VA, Gianotti MA, Almeida OP, Saldiva PH, Mauad T (2000) Uncommon histopathological findings in fatal measles infection: pancreatitis, sialoadenitis and thyroiditis. Histopathology 37:141–146
Vasko VV, Gaudart J, Allasia C, Savchenko V, Di Cristofaro J, Saji M, Ringel MD, De Micco C (2004) Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma. Eur J Endocrinol 151:779–786
Veits L, Mechtersheimer G, Steger C, Freitag J, Mikuz G, Schmid KW, Hofmann W, Schirmacher P, Hartmann A, Rieker RJ (2011) Chromosomal imbalances in carcinoma showing thymus-like elements (CASTLE). Virchows Arch 459:221–226
Vergilio J, Baloch ZW, LiVolsi VA (2002) Spindle cell metaplasia of the thyroid arising in association with papillary carcinoma and follicular adenoma. Am J Clin Pathol 117:199–204
Verkooijen HM, Fioretta G, Pache JC, Franceschi S, Raymond L, Schubert H, Bouchardy C (2003) Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14:13–17
Vickery AL Jr, Carcangiu ML, Johannessen JV, Sobrinho-Simoes M (1985) Papillary carcinoma. Semin Diagn Pathol 2:90–100
Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhäusl A, Niederle B (1997) Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82:1589–1593
Villa F, Dionigi G, Tanda ML, Rovera F, Boni L (2008) Amyloid goiter. Int J Surg 6 Suppl 1:16–18
Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E, Liu CG, Petrocca F, Troncone G, Calin GA, Scarpa A, Colato C, Tallini G, Santoro M, Croce CM, Fusco A (2007) Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26:7590–7595
Volante M, Papotti M, Roth J, Saremaslani P, Speel EJ, Lloyd RV, Carney JA, Heitz PU, Bussolati G, Komminoth P (1999) Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components. Am J Pathol 155:1499–1509
Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256–1264
Volante M, Rapa I, Gandhi M, Bussolati G, Giachino D, Papotti M, Nikiforov YE (2009) RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab 94:4735–4741
Vriens MR, Schreinemakers JM, Suh I, Guerrero MA, Clark OH (2009) Diagnostic markers and prognostic factors in thyroid cancer. Future Oncol 5:1283–1293
Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283:1482–1488
Wan SK, Chan JK, Tang SK (1996) Paucicellular variant of anaplastic thyroid carcinoma. A mimic of Reidel’s thyroiditis. Am J Clin Pathol 105:388–393
Wang K, Klionsky DJ (2011) Mitochondria removal by autophagy. Autophagy 7:297–300
Wang SA, Rahemtullah A, Faquin WC, Roepke J, Harris NL, Hasserjian RP (2005) Hodgkin’s lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature. Mod Pathol 18:1577–1584
Wartofsky L (2012) Management of papillary microcarcinoma: primum non nocere? J Clin Endocrinol Metab 97:1169–1172 (Erratum in: J Clin Endocrinol Metab 97: 1786)
Weber A, Schmid KW, Tannapfel A, Wittekind C (2010) Neuerungen der TNM-Klassifikation der Kopf-Hals-Tumoren. Pathologe 31:339–343
Weetman AP (2001) Determinants of autoimmune thyroid disease. Nat Immunol 2:769–770
Weinhaeusel A, Scheuba C, Lauss M, Kriegner A, Kaserer K, Vierlinger K, Haas OA, Niederle B (2008) The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma. Thyroid 18:1269–1276
Wenig BM, Heffess CS, Adair CF (1997) Thyroid paraganglioma. In: Atlas of Endocrine Pathology. W.B. Saunders, Philadelphia, S 144
Williams D (2008) Radiation carcinogenesis: lessons from Chernobyl. Oncogene 2:9–18
Williams ED, Toyn CE, Harach HR (1989) The ultimobranchial gland and congenital thyroid abnormalities in man. J Pathol 159:135–141
Williams ED (2000) Guest Editorial: Two Proposals Regarding the Terminology of Thyroid Tumors. Int J Surg Pathol 8:181–183
Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH (2003) TNM Supplement. A commentary on uniform use, 3. Aufl. Wiley-Liss, New York, S 138
Wohllk N, Schweizer H, Erlic Z, Schmid KW, Walz MK, Raue F, Neumann HP (2010) Multiple endocrine neoplasia type 2. Best Pract Res Clin Endocrinol Metab 24:371–387
Wohlschlaeger J, Ebert S, Sheu SY, Schmid KW, Totsch M (2009) Immunocytochemical investigation of Langerin (CD207) is a valuable adjunct in the cytological diagnosis of Langerhans cell histiocytosis of the thyroid. Pathol Res Pract 205:433–436
Wolfe HJ, DeLellis RA, Voelkel EF, Tashjian AH Jr (1975) Distribution of calcitonin-containing cells in the normal neonatal human thyroid gland: a correlation of morphology with peptide content. J Clin Endocrinol Metab 41:1076–1081
Woo Young K, Young Ran K, Sang Uk W, Jae Bok L (2011) Pulmonary leiomyosarcoma metastatic to the thyroid gland: case report and review of the literature. Ann Endocrinol 72:314–316
Wreesmann VB, Ghossein RA, Hezel M, Banerjee D, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B (2004) Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer 40:355–364
Wu G, Mambo E, Guo Z, Hu S, Huang X, Gollin SM, Trink B, Ladenson PW, Sidransky D, Xing M (2005) Uncommon mutation, but common amplifications, of the PIK3CA gene in thyroid tumors. JCEM 90:4688–4693
Wynford-Thomas D (1994) Thyroid cancer. In: Lemoine N, Neoptolemos J, Cooke T (Hrsg) Cancer. A molecular approach. Blackwell Scientific Publications, London, S 192–222
Xia CX, Li R, Wang ZH, Lv FJ, Tang XQ, Li QF, Zhang SH (2012) A rare cause of goiter: Langerhans cell histiocytosis of the thyroid. Endocr J 59:47–54
Xing M (2005) BRAF mutation in thyroid cancer. Endocr Relat Cancer 12:245–26
Xing M (2008) Recent advances in molecular biology of thyroid cancer and their clinical implications. Otolaryngol Clin North Am 41:1135–1146
Xing M (2010) Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer. Thyroid 20:697–706
Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, Pai S, Bishop J (2014) BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol 32:2718–2726
Xu B, Hirokawa M, Yoshimoto K, Miki H, Takahashi M, Kuma S, Sano T (2003) Spindle epithelial tumor with thymus-like differentiation of the thyroid: a case report with pathological and molecular genetics study. Hum Pathol 34:190–193
Yagawa K, Takahashi S, Murata T (1966) Clinico-pathological study of latent thyroid carcinoma. Proceedings of the Japanese Cancer Association, 25th Annual Meeting 106 (abstract)
Yamamoto Y, Maeda T, Izumi K, Otsuka H (1990) Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer 65:1173–1179
Yu XM, Wan Y, Sippel RS, Chen H (2011) Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg 254:653–660
Zantour B, Guilhaume B, Tissier F, Louvel A, Jeunemaitre X, Gimenez-Roqueplo AP, Bertagna X (2004) A thyroid nodule revealing a paraganglioma in a patient with a new germline mutation in the succinate dehydrogenase B gene. Eur J Endocrinol 151:433–438
Zheng X, Wei S, Han Y, Li Y, Yu Y, Yun X, Ren X, Gao M (2013) Papillary Microcarcinoma of the Thyroid: Clinical Characteristics and BRAF(V600E) Mutational Status of 977 Cases. Ann Surg Oncol 20:2266–2273
Zhu Z, Gandhi M, Nikiforova MN, Fischer AH, Nikiforov YE (2003) Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol 120:71–77
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schmid, K.W., Sheu-Grabellus, SY. (2016). Schilddrüse. In: Amann, K., Kain, R., Klöppel, G. (eds) Pathologie. Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04566-0_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-04566-0_19
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-04565-3
Online ISBN: 978-3-642-04566-0
eBook Packages: Medicine (German Language)